INS and type 2 diabetes mellitus: TZDs also reduce serum lipid levels in rodents and humans suffering from non-insulin-dependent diabetes mellitus (NIDDM) [21], which reduce plasma triglyceride, fatty acid, and insulin levels and increase HDL cholesterol levels [22, 23].